{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:07:47Z","timestamp":1791659267088,"version":"4.3.4"},"reference-count":99,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Unfractionated heparin (UFH) remains the standard anticoagulant for extracorporeal membrane oxygenation (ECMO), despite complications, such as heparin resistance, heparin-induced thrombocytopenia, bleeding and variable pharmacokinetics. This has prompted the search for alternative and novel anticoagulation strategies, including pharmacologic agents, circuit modifications, and monitoring approaches. This scoping review aimed to map the breadth and characteristics of evidence on ECMO anticoagulation strategies beyond UFH. Methods: A comprehensive search of peer-reviewed and gray literature was conducted across PubMed, Cochrane, Clinical Trials, WHO Trials Registry, and conference abstracts through manual searches in key journals. Clinical, pre-clinical, and gray literature studies evaluating pharmacologic agents, anticoagulation-free or heparin-sparing, biocompatible circuits, and monitoring innovations were included. Data were charted and synthesized descriptively to identify trends, gaps, and emerging directions. Results: A total of 269 records were included. Evidence was highly heterogeneous among study designs, populations, ECMO modalities, and outcome definitions. Most clinical studies were retrospective cohorts and adult-centered, with limited multicenter randomized controlled trials and underrepresentation of neonatal and pediatric populations. Direct thrombin inhibitors were frequently studied and clinically implemented alternatives to UFH. Other agents, including nafamostat mesylate, prostaglandin E1, and factor pathway inhibitors remain early in clinical investigation. Anticoagulation-free strategies and biocompatible circuit technologies were mostly supported through pre-clinical and single-center studies. Monitoring and modeling innovations, like TEG, ROTEM, real-time imaging, and machine learning, are quickly emerging. Conclusions: ECMO anticoagulation is transitioning from UFH reliance toward diversified and personalized strategies. Future research should prioritize multicenter randomized controlled trials, standardize protocols, expand to neonatal and pediatric investigation, and integrate strategies.<\/jats:p>","DOI":"10.3390\/jcm15062337","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:12:26Z","timestamp":1773853946000},"page":"2337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alternate and Emerging Anticoagulation Strategies for Extracorporeal Membrane Oxygenation: A Scoping Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2718-0606","authenticated-orcid":false,"given":"Akshay","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, New York University Langone Health, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Carlo","sequence":"additional","affiliation":[{"name":"John Hopkins School of Public Health, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6415-7724","authenticated-orcid":false,"given":"Rithish","family":"Nimmagadda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, One Brooklyn Health, New York, NY 11213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juber Dastagir","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Henry Ford Hospital, Detroit, MI 48202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourabh","family":"Khatri","sequence":"additional","affiliation":[{"name":"Independent Health System, Greensburg, PA 15601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Medicine, Prisma Health, University of South Carolina School of Medicine, Columbia, SC 29203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"ref_1","unstructured":"Vyas, A., Patel, V., and Wang, C.F. (2025, November 02). Extracorporeal Membrane Oxygenation in Adults, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576426\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12055-021-01176-3","article-title":"Anticoagulation in ECMO patients: An overview","volume":"37","author":"Kumar","year":"2021","journal-title":"Indian J. Thorac. Cardiovasc. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Frantzeskaki, F., Konstantonis, D., Rizos, M., Kitsinelis, V., Skyllas, G., Renieris, I., Doumani, M., Kolias, V., Kefalidi, E., and Angouras, D. (2023). Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults. Diagnostics, 13.","DOI":"10.20944\/preprints202310.1071.v1"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ranucci, M., Cotza, M., and Di Dedda, U. (2022). Bleeding and Thrombotic Issues during Extracorporeal Membrane Oxygenation. J. Clin. Med., 11.","DOI":"10.3390\/jcm11185375"},{"key":"ref_5","first-page":"100216","article-title":"Anticoagulation Management During ECMO: Narrative Review","volume":"8","author":"Vatjer","year":"2025","journal-title":"J. Heart Lung Transplant. Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1053\/j.jvca.2025.05.058","article-title":"Evaluation of Intraoperative Bivalirudin Anticoagulation in Neonates and Infants Undergoing Arterial Switch Operation on Integrated ECMO-CPB Circuit: A Prospective Study","volume":"39","author":"Badge","year":"2025","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/j.jvca.2025.03.041","article-title":"Comparative Analysis of Thrombosis in ECPella Patients Between Bivalirudin versus Heparin Anticoagulation Strategies","volume":"39","author":"Cho","year":"2025","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_9","first-page":"133","article-title":"Bleeding Complications between Bivalirudin and Heparin for Extracorporeal Membrane Oxygenation in Neonates with Congenital Diaphragmatic Hernia","volume":"52","author":"Credille","year":"2025","journal-title":"Fetal Diagn. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Daniels, Z., Walczak, A.B., Lloyd, E.A., Wright, L.K., Nandi, D., Deitemyer, M., Duffy, V., Kistler, I.S., Conroy, S., and Carrillo, S.A. (ASAIO J., 2025). A Comparative Analysis of Bivalirudin and Heparin for Extracorporeal Membrane Oxygenation in a Pediatric Cardiothoracic Intensive Care Unit, ASAIO J., ahead of print.","DOI":"10.1097\/MAT.0000000000002598"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/j.jvca.2025.01.041","article-title":"Heparin Versus Bivalirudin in Pediatric Patients Assisted with Mechanical Circulatory Support: A Retrospective Before-and-after Study","volume":"39","author":"Giorni","year":"2025","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lofy, T., Juul, J., Duewell, B., Tchen, S., Held-Godgluck, B., Brazauskas, R., and Feih, J. (2025). Retrospective, Single-Center Cohort Study of Bivalirudin Compared to Unfractionated Heparin in Patients Receiving Extracorporeal Membrane Oxygenation. Ann. Pharmacother., 10600280251371081.","DOI":"10.1177\/10600280251371081"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/PCC.0000000000003642","article-title":"Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation","volume":"26","author":"McMichael","year":"2025","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MAT.0000000000002411","article-title":"Prolonged Use of Extracorporeal Membrane Oxygenators for COVID-19-Associated Acute Respiratory Distress Syndrome: A Retrospective Analysis","volume":"71","author":"Altinay","year":"2025","journal-title":"ASAIO J."},{"key":"ref_15","first-page":"218","article-title":"Evaluation of a Bivalirudin Dosing and Monitoring Protocol in Pediatric Extracorporeal Membrane Oxygenation","volume":"30","author":"Smith","year":"2025","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_16","first-page":"170","article-title":"Should I Change Anticoagulane in Veno-Venous ECMO?","volume":"53","author":"Arslan","year":"2025","journal-title":"Turk. J. Anaesthesiol. Reanim."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/MAT.0000000000002094","article-title":"Management of Bivalirudin Dosing and Replacement Fluid During Therapeutic Plasma Exchange in Children on Extracorporeal Membrane Oxygenation","volume":"70","author":"Chomat","year":"2024","journal-title":"ASAIO J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/PCC.0000000000003527","article-title":"Bivalirudin Monitoring in Pediatric Ventricular Assist Device and Extracorporeal Membrane Oxygenation: Analysis of Single-Center Retrospective Cohort Data 2018\u20132022","volume":"25","author":"Engel","year":"2024","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MAT.0000000000002172","article-title":"Unresponsiveness of Activated Partial Thromboplastin Time to Bivalirudin in Adults Receiving Extracorporeal Membrane Oxygenation","volume":"70","author":"Jatis","year":"2024","journal-title":"ASAIO J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ejh.14146","article-title":"Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin","volume":"112","author":"Kartika","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/00185787231188924","article-title":"Evaluation of Bivalirudin During Adult Extracorporeal Membrane Oxygenation: A Retrospective Characterization of Dosing, Efficacy and Bleeding","volume":"59","author":"Lopez","year":"2024","journal-title":"Hosp. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1053\/j.jvca.2024.02.039","article-title":"Comparison of Outcomes in Patients Requiring Mechanical Circulatory Support Who Received Cangrelor in Addition to Anticoagulation Versus Anticoagulation Alone","volume":"38","author":"Martin","year":"2024","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5606\/tgkdc.dergisi.2024.25230","article-title":"Anticoagulation strategy with bivalirudin plus aspirin combination during extracorporeal membrane oxygenation for COVID-19-associated acute respiratory distress syndrome","volume":"32","year":"2024","journal-title":"Turk. J. Thorac. Cardiovasc. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/MAT.0000000000001871","article-title":"Anti-thrombotic Therapy with Cangrelor and Bivalirudin in Venoarterial Extracorporeal Membrane Oxygenation Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Experience","volume":"69","author":"Baldetti","year":"2023","journal-title":"ASAIO J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/phar.2776","article-title":"Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation","volume":"43","author":"Buckley","year":"2023","journal-title":"Pharmacotherapy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1051\/ject\/2023027","article-title":"Anticoagulation strategies in COVID-19 infected patients receiving ECMO support","volume":"55","author":"Diaz","year":"2023","journal-title":"J. Extra Corpor. Technol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.thromres.2023.07.012","article-title":"Bivalirudin or heparin for systemic anticoagulation during pediatric extracorporeal membrane oxygenation: Multicenter retrospective study","volume":"229","author":"Hamzah","year":"2023","journal-title":"Thromb. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/02676591211034314","article-title":"Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO)","volume":"38","author":"Kaushik","year":"2023","journal-title":"Perfusion"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1097\/CCM.0000000000005821","article-title":"Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared with Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation","volume":"51","author":"Seelhammer","year":"2023","journal-title":"Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/03913988221148763","article-title":"Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study","volume":"46","author":"Tong","year":"2023","journal-title":"Int. J. Artif. Organs"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MAT.0000000000001723","article-title":"Bivalirudin Versus Unfractionated Heparin in Patients with Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation","volume":"69","author":"Uricchio","year":"2023","journal-title":"ASAIO J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/10600280211036151","article-title":"Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure","volume":"56","author":"Bissell","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/MAT.0000000000001818","article-title":"Evaluation of Bivalirudin Dosing in Pediatric Extracorporeal Membrane Oxygenation with Renal Insufficiency or Renal Replacement Therapy","volume":"68","author":"Hamzah","year":"2022","journal-title":"ASAIO J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/03913988221106225","article-title":"Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation","volume":"45","author":"Hanna","year":"2022","journal-title":"Int. J. Artif. Organs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/MAT.0000000000001681","article-title":"Impact of Continuous Renal Replacement Therapy on Bivalirudin Dosing in Pediatric Extracorporeal Membrane Oxygenation","volume":"68","author":"Lahart","year":"2022","journal-title":"ASAIO J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1053\/j.jvca.2022.03.004","article-title":"Anticoagulation Strategies in Critically Ill Patients with SARS-CoV-2 Infection: The Role of Direct Thrombin Inhibitors","volume":"36","author":"Pieri","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/MAT.0000000000001582","article-title":"Poor Reliability of Common Measures of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation","volume":"68","author":"Rabinowitz","year":"2022","journal-title":"ASAIO J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/MAT.0000000000001781","article-title":"Outcomes with Direct and Indirect Thrombin Inhibition During Extracorporeal Membrane Oxygenation for COVID-19","volume":"68","author":"Saeed","year":"2022","journal-title":"ASAIO J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1051\/ject\/202254223","article-title":"Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients","volume":"54","author":"Stammers","year":"2022","journal-title":"J. Extra Corpor. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ijlh.13780","article-title":"How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods","volume":"44","author":"Teruya","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.jvca.2021.10.026","article-title":"Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support","volume":"36","author":"Trigonis","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1060028020937819","article-title":"Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support","volume":"55","author":"Campbell","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MAT.0000000000001291","article-title":"Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation","volume":"67","author":"Machado","year":"2021","journal-title":"ASAIO J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/CCM.0000000000004944","article-title":"Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin","volume":"49","author":"Rivosecchi","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","article-title":"Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation","volume":"49","author":"Seelhammer","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/aor.13758","article-title":"Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center","volume":"45","author":"Schill","year":"2021","journal-title":"Artif. Organs"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/PCC.0000000000002384","article-title":"Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation","volume":"21","author":"Hamzah","year":"2020","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jocs.14458","article-title":"Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation","volume":"35","author":"Kaseer","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.thromres.2020.05.020","article-title":"Age-specific differences in the in vitro anticoagulant effect of Bivalirudin in healthy neonates and children compared to adults","volume":"192","author":"Letunica","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/PCC.0000000000002527","article-title":"Prospective Exploratory Experience with Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation","volume":"21","author":"Ryerson","year":"2020","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.thromres.2020.07.043","article-title":"A perioperative bivalirudin anticoagulation protocol for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation","volume":"193","author":"Snyder","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.12.007","article-title":"Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing","volume":"186","author":"Teruya","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/0267659119842809","article-title":"Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy","volume":"34","author":"Macielak","year":"2019","journal-title":"Perfusion"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MAT.0000000000000780","article-title":"Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support with or Without Continuous Renal Replacement Therapy","volume":"65","author":"Walker","year":"2019","journal-title":"ASAIO J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MAT.0000000000000691","article-title":"Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation","volume":"64","author":"Berei","year":"2018","journal-title":"ASAIO J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/tme.13102","article-title":"A safety comparison of heparin and argatroban anticoagulation in veno-venous extracorporeal membrane oxygenation with a focus on bleeding","volume":"35","author":"Sagan","year":"2025","journal-title":"Transfus. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"10760296251341315","DOI":"10.1177\/10760296251341315","article-title":"Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation","volume":"31","author":"Frelich","year":"2025","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.thromres.2024.02.026","article-title":"Anticoagulation with argatroban using hemoclotTM targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study","volume":"236","author":"Joannidis","year":"2024","journal-title":"Thromb. Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Schiavoni, L., Mattei, A., Cuccarelli, M., Strumia, A., Dominici, C., Nenna, A., Aceto, J., Palazzo, G., Pascarella, G., and Costa, F. (2024). Anticoagulation Management for Veno-Venous ECMO in COVID-19 Patients: Argatroban as Rescue Therapy in Heparin-Associated Thrombocytopenia. J. Clin. Med., 13.","DOI":"10.21203\/rs.3.rs-4613926\/v1"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e13963","DOI":"10.1111\/eci.13963","article-title":"Membrane oxygenator longevity was higher in argatroban-treated patients undergoing vvECMO","volume":"53","author":"Menninger","year":"2023","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0018578719890091","article-title":"Cost-effectiveness of Argatroban Versus Heparin Anticoagulation in Adult Extracorporeal Membrane Oxygenation Patients","volume":"56","author":"Cho","year":"2021","journal-title":"Hosp. Pharm."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13054-021-03581-x","article-title":"Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: A propensity-score matched study","volume":"25","author":"Fisser","year":"2021","journal-title":"Crit. Care"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2020.02.021","article-title":"Argatroban dosing requirements in extracorporeal life support and other critically ill populations","volume":"189","author":"Dingman","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13613-017-0302-5","article-title":"Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support","volume":"7","author":"Menk","year":"2017","journal-title":"Ann. Intensive Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4266\/acc.2021.01312","article-title":"The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation","volume":"37","author":"Lee","year":"2022","journal-title":"Acute Crit. Care"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.21037\/jtd.2019.06.30","article-title":"Single-center experience of extracorporeal membrane oxygenation mainly anticoagulated with nafamostat mesilate","volume":"11","author":"Han","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.athoracsur.2016.01.044","article-title":"Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin","volume":"102","author":"Lim","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e1206","DOI":"10.1097\/CCM.0000000000005179","article-title":"Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane Oxygenation","volume":"49","author":"Buchtele","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.21037\/apm-20-1487","article-title":"A new anticoagulation strategy using recombinant human thrombomodulin in patients on veno-venous extracorporeal membrane oxygenation: A retrospective study","volume":"10","author":"Yasuda","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1164\/rccm.202110-2359OC","article-title":"Add-On Prostaglandin E1 in Venovenous Extracorporeal Membrane Oxygenation: A Randomized, Double-Blind, Placebo-controlled Pilot Trial","volume":"206","author":"Buchtele","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/1060028021994621","article-title":"Clinical Use of Cangrelor After Percutaneous Coronary Intervention in Patients Requiring Mechanical Circulatory Support","volume":"55","author":"Katz","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MAT.0000000000001003","article-title":"Continuous Renal Replacement Therapy in Venovenous Extracorporeal Membrane Oxygenation: A Retrospective Study on Regional Citrate Anticoagulation","volume":"66","author":"Giani","year":"2020","journal-title":"ASAIO J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10047-025-01541-8","article-title":"Feasibility of anticoagulation-free peripheral veno-arterial extracorporeal membrane oxygenation in re-do lung transplantation","volume":"29","author":"Kurihara","year":"2025","journal-title":"J. Artif. Organs"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"17534666241273012","DOI":"10.1177\/17534666241273012","article-title":"The impact of early perioperative heparin-free anticoagulation for extracorporeal membrane oxygenation on bleeding and thrombotic events in lung transplantation: A retrospective cohort study","volume":"18","author":"Qi","year":"2024","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12959-022-00396-w","article-title":"Heparin-free after 3000\u2009IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: A novel anti-coagulation strategy","volume":"20","author":"Zhao","year":"2022","journal-title":"Thromb. J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.athoracsur.2019.08.040","article-title":"Venoarterial-Extracorporeal Membrane Oxygenation Without Routine Systemic Anticoagulation Decreases Adverse Events","volume":"109","author":"Wood","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jss.2019.05.050","article-title":"Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO","volume":"243","author":"Carter","year":"2019","journal-title":"J. Surg. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jtha.2025.02.020","article-title":"Comparison of the effects of phosphorylcholin versus heparin-based surface coating on clinical and histologic outcomes during veno-arterial extracorporeal membrane oxygenation support: A propensity score weighted analysis","volume":"23","author":"Moussa","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Malik, M.I., Aboelnazar, N.S., Rheault-Henry, M., Vo, T.X., and Nagpal, A.D. (2026). Cumulative elevation of aPTT predicts time to major bleeding and death in ECMO: A joint longitudinal-survival model. Perfusion, 2676591251412301.","DOI":"10.1177\/02676591251412301"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1177\/02676591251324648","article-title":"Quantitative methods to improve bivalirudin dosing in pediatric cardiac ICU patients","volume":"40","author":"Brinkley","year":"2025","journal-title":"Perfusion"},{"key":"ref_81","first-page":"e0776","article-title":"Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated with Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation","volume":"4","author":"Frydman","year":"2022","journal-title":"Crit. Care Explor."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MAT.0000000000001196","article-title":"Thromboelastometry, Thromboelastography, and Conventional Tests to Assess Anticoagulation During Extracorporeal Support: A Prospective Observational Study","volume":"67","author":"Giani","year":"2021","journal-title":"ASAIO J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13613-017-0352-8","article-title":"Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: A safety and feasibility pilot study","volume":"8","author":"Panigada","year":"2018","journal-title":"Ann. Intensive Care"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1051\/ject\/201850149","article-title":"Use of Thromboelastography to Predict Thrombotic Complications in Pediatric and Neonatal Extracorporeal Membranous Oxygenation","volume":"50","author":"Henderson","year":"2018","journal-title":"J. Extra Corpor. Technol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","article-title":"Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey","volume":"14","author":"Bembea","year":"2013","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO Adult and Pediatric Anticoagulation Guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/PCC.0000000000002696","article-title":"Pediatric ECMO (PediECMO) Subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Extracorporeal Life Support Organization (ELSO). Anticoagulation and Transfusion Management During Neonatal and Pediatric Extracorporeal Membrane Oxygenation: A Survey of Medical Directors in the United States","volume":"22","author":"Ozment","year":"2021","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Navaei, A., Kostousov, V., and Teruya, J. (2023). Is it time to switch to bivalirudin for ECMO anticoagulation?. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1237601"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Unic-Stojanovic, D., Vukovic, P., Stojicic, M.M., Tanaskovic, S., Kangrga, N., and Rajsic, S. (2025). Alternative Anticoagulation for Patients with Heparin-Induced Thrombocytopenia on ECMO: A Narrative Review. Biomedicines, 13.","DOI":"10.3390\/biomedicines13112705"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Rajsic, S., Breitkopf, R., Jadzic, D., Popovic Krneta, M., Tauber, H., and Treml, B. (2022). Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175147"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12959-023-00452-z","article-title":"Current and future strategies to monitor and manage coagulation in ECMO patients","volume":"21","author":"Carberry","year":"2023","journal-title":"Thromb. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"100064","DOI":"10.1016\/j.bvth.2025.100064","article-title":"ECMO-induced coagulopathy: Strategic initiatives for research and clinical practice (a workshop report of the NHLBI)","volume":"2","author":"Levy","year":"2025","journal-title":"Blood Vessel. Thromb. Hemost."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PCC.0000000000003496","article-title":"The Influence of the Extracorporeal Membrane Oxygenation Circuit and Components on Anticoagulation Management: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference","volume":"25","author":"Himebauch","year":"2024","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MAT.0000000000001785","article-title":"The Evolution of Extracorporeal Membrane Oxygenation Circuitry and Impact on Clinical Outcomes in Children: A Systematic Review","volume":"69","author":"Cai","year":"2023","journal-title":"ASAIO J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s13054-020-03403-6","article-title":"Machine learning to predict hemorrhage and thrombosis during extracorporeal membrane oxygenation","volume":"24","author":"Abbasi","year":"2020","journal-title":"Crit. Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"41581","DOI":"10.1038\/s41598-025-25423-4","article-title":"Development and validation of a machine learning model for predicting mortality risk in veno-arterial extracorporeal membrane oxygenation patients","volume":"15","author":"Gao","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13054-024-05248-9","article-title":"Development and external validation of a machine learning model for brain injury in pediatric patients on extracorporeal membrane oxygenation","volume":"29","author":"Deng","year":"2025","journal-title":"Crit. Care"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/trf.18261","article-title":"Machine learning-based prediction of bleeding risk in extracorporeal membrane oxygenation patients using transfusion as a surrogate marker","volume":"65","author":"Kamio","year":"2025","journal-title":"Transfusion"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/PCC.0000000000003679","article-title":"Hemostatic Outcome Definitions in Pediatric Extracorporeal Membrane Oxygenation: Challenges in Cohorts from Rotterdam (2019\u20132023) and Melbourne (2016\u20132022)","volume":"26","author":"Drop","year":"2025","journal-title":"Pediatr. Crit. Care Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:29:16Z","timestamp":1773912556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":99,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15062337"],"URL":"https:\/\/doi.org\/10.3390\/jcm15062337","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}